Home / Pharma Healthcare / Global Bio-Artificial Systems Sales Market Report 2016

Global Bio-Artificial Systems Sales Market Report 2016

  • Id : RNR-15776
  • Category : Pharma Healthcare
  • Publish Date : 6-Oct
  • Pages : 125
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Bio-Artificial Systems
Revenue, means the sales value of Bio-Artificial Systems

This report studies sales (consumption) of Bio-Artificial Systems in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
    Xenios AG (Germany)
    Abbott Diabetes Care, Inc. (USA)
    Vital Therapies, Inc. (USA)
    Baxter International, Inc. (USA)
    Asahi Kasei Medical Co., Ltd. (Japan)
    Medtronic, Inc. (USA)
    HeartWare International, Inc. (USA)
    Fresenius Medical Care AG & Co. KGaA (Germany)
    Thoratec Corp. (USA)
    Toray Medical Co., Ltd. (Japan)
    Nikkiso Co., Ltd. (Japan)
    Nipro Corporation (Japan)
    SynCardia Systems, Inc. (USA)
    Terumo Heart, Inc. (USA)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Bio-Artificial Systems in these regions, from 2011 to 2021 (forecast), like
    USA
    China
    Europe
    Japan
    India
    Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
    Capillary Hollow Fiber Systems
    Direct Perfusion Systems
    Entrapment Based Systems
    Major BAL Devices
    Extracorporeal Liver Assist Device (ELAD)
    Hybrid Artificial Liver Support System
Split by applications, this report focuses on sales, market share and growth rate of Bio-Artificial Systems in each application, can be divided into
    Application 1
    Application 2
    Application 3